Funding for this research was provided by:
Instituto de Salud Carlos III (ICI21/00042, RD16/0009/0006, RD16/0009/0030, RD16/0009/0031, RD21/0005/0012, RD21/0005/0016)
Received: 9 June 2022
Accepted: 24 October 2022
First Online: 7 November 2022
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Provincial Ethics and Clinical Research Committee of Malaga (CEI Provincial Malaga) and by the Spanish Drug Agency (protocol code: TRAINING and date of approval: 08 March 2022).Informed consent will be obtained in writing from all subjects involved in the study.
: Not applicable.
: The authors declare no conflict of interest.